Alpine Associates Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Alpine Associates Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-865,500	Closed	-$34.4M	–	73
2026 Q1	$34.4M	Buy	+865,500	New	+$22.1M	2.03%	14

Alpine Associates Management's CNTA Position: Q2 2026 in Review

Alpine Associates Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 865,500 shares — an estimated $34.4M sold.

Alpine Associates Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $34.4M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Alpine Associates Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Alpine Associates Management sold 865,500 Centessa Pharmaceuticals shares in Q2 2026, an estimated $34.4M.
Alpine Associates Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Alpine Associates Management's Centessa Pharmaceuticals position peaked at $34.4M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Alpine Associates Management's 13F filing for Q2 2026, filed 6 Aug 2026.